STERIS plc (NYSE:STE) Stake Raised by OneAscent Wealth Management LLC

OneAscent Wealth Management LLC grew its holdings in shares of STERIS plc (NYSE:STE) by 7.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,856 shares of the medical equipment provider’s stock after buying an additional 200 shares during the period. OneAscent Wealth Management LLC’s holdings in STERIS were worth $693,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. West Coast Financial LLC increased its stake in shares of STERIS by 2.8% during the third quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider’s stock valued at $398,000 after acquiring an additional 45 shares during the period. Taylor Frigon Capital Management LLC increased its stake in shares of STERIS by 0.8% during the second quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider’s stock valued at $1,356,000 after acquiring an additional 46 shares during the period. Mather Group LLC. increased its stake in shares of STERIS by 7.6% during the second quarter. Mather Group LLC. now owns 763 shares of the medical equipment provider’s stock valued at $172,000 after acquiring an additional 54 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of STERIS by 16.5% during the first quarter. EverSource Wealth Advisors LLC now owns 402 shares of the medical equipment provider’s stock valued at $82,000 after acquiring an additional 57 shares during the period. Finally, Waterloo Capital L.P. increased its stake in shares of STERIS by 3.2% during the second quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider’s stock valued at $421,000 after acquiring an additional 59 shares during the period. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other STERIS news, CFO Michael J. Tokich sold 23,332 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total value of $5,763,004.00. Following the transaction, the chief financial officer now directly owns 42,930 shares in the company, valued at $10,603,710. The trade was a 35.21 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on STE. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, November 8th. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Wednesday, August 7th. Piper Sandler upgraded shares of STERIS from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $230.00 to $260.00 in a research report on Thursday, October 24th. StockNews.com lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Finally, Stephens restated an “overweight” rating and issued a $260.00 price target on shares of STERIS in a research report on Thursday, November 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $253.00.

STERIS Stock Performance

STE traded up $0.21 during trading on Monday, hitting $220.33. The stock had a trading volume of 33,692 shares, compared to its average volume of 490,629. The firm has a market cap of $21.75 billion, a PE ratio of 50.26 and a beta of 0.85. STERIS plc has a 12 month low of $195.47 and a 12 month high of $248.24. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. The company has a 50 day simple moving average of $230.37 and a 200-day simple moving average of $228.59.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.12 by $0.02. The company had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The business’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.03 EPS. Analysts expect that STERIS plc will post 9.15 EPS for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Tuesday, November 19th will be paid a $0.57 dividend. The ex-dividend date is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS’s payout ratio is currently 52.05%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.